A critical advance in cancer research is emerging with the use of mini-antibodies to re-engage mutated p53. This essential malignant suppressor protein is frequently inactivated in several forms of tumors, resulting https://bookmarklethq.com/story21919326/nanobodies-restore-p53-new-potential-hope-for-malignant-therapy